We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Rules Out "At-Risk" Lipitor Launch: Report

Law360 (January 26, 2005, 12:00 AM EST) -- Indian generic maker Ranbaxy Laboratories Ltd. won’t launch a generic version of Pfizer Inc.’s best-selling anti-cholesterol drug Lipitor “at risk” if it wins its patent challenge at the district-court level, according...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.